Clinical in brief Inspra: for reducing MI mortality in heart failureInspra (eplerenone 25 mg and 50 mg tablets), Pfizer. Stent-graft placement feasible for dysfunctional hemodialysis fistulas Health Canada advisories: June 2009 Medication-related hospitalizations Statin a bust for lowering heart risk in end-stage renal disease Cholesterol fighter one of many interventions that has failed to improve survival and cardiovascular outcomes in these patients AUA: Obesity linked to increased risk for urinary tract infection Risk of kidney infection five times higher and risk of bladder infection more than double that of non-obese patients CARDIOLOGY: Resistant hypertension responds to renal sympathetic denervation Zapping the renal sympathetic nerves with radiofrequency energy may offer hope to patients unable to control their hypertension despite multiple high-dose medications. Picture This Diabetes Update 09: Guiding Light A look at what's new in the Canadian clinical practice guidelines for diabetes First Previous 71 72 73 74 75 Next Last
